Targeting Autophagy to Overcome Human Diseases

被引:106
作者
Condello, Maria [1 ]
Pellegrini, Evelin [1 ]
Caraglia, Michele [2 ]
Meschini, Stefania [1 ]
机构
[1] Natl Ctr Drug Res & Evaluat, Natl Inst Hlth, Viale Regina Elena, I-00161 Rome, Italy
[2] Univ Campania Luigi Vanvitelli, Dept Precis Med, I-80138 Naples, Italy
关键词
autophagy; cell survival; cell death; target therapy; inflammation; metabolic diseases; neurodegenerative diseases; autoimmune diseases; aging; cancer; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; REGULATORY T-CELLS; CALORIE RESTRICTION; SELECTIVE AUTOPHAGY; INSULIN-RESISTANCE; CROHNS-DISEASE; CANCER-CELLS; PROTEIN; MECHANISMS;
D O I
10.3390/ijms20030725
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autophagy is an evolutionarily conserved cellular process, through which damaged organelles and superfluous proteins are degraded, for maintaining the correct cellular balance during stress insult. It involves formation of double-membrane vesicles, named autophagosomes, that capture cytosolic cargo and deliver it to lysosomes, where the breakdown products are recycled back to cytoplasm. On the basis of degraded cell components, some selective types of autophagy can be identified (mitophagy, ribophagy, reticulophagy, lysophagy, pexophagy, lipophagy, and glycophagy). Dysregulation of autophagy can induce various disease manifestations, such as inflammation, aging, metabolic diseases, neurodegenerative disorders and cancer. The understanding of the molecular mechanism that regulates the different phases of the autophagic process and the role in the development of diseases are only in an early stage. There are still questions that must be answered concerning the functions of the autophagy-related proteins. In this review, we describe the principal cellular and molecular autophagic functions, selective types of autophagy and the main in vitro methods to detect the role of autophagy in the cellular physiology. We also summarize the importance of the autophagic behavior in some diseases to provide a novel insight for target therapies.
引用
收藏
页数:27
相关论文
共 146 条
  • [11] HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE
    Caza, Tiffany N.
    Fernandez, David R.
    Talaber, Gergely
    Oaks, Zachary
    Haas, Mark
    Madaio, Michael P.
    Lai, Zhi-wei
    Miklossy, Gabriella
    Singh, Ram R.
    Chudakov, Dmitriy M.
    Malorni, Walter
    Middleton, Frank
    Banki, Katalin
    Perl, Andras
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (10) : 1888 - 1897
  • [12] The independence of and associations among apoptosis, autophagy, and necrosis
    Chen, Qi
    Kang, Jian
    Fu, Caiyun
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2018, 3
  • [13] Mechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases
    Chu, Charleen T.
    [J]. NEUROBIOLOGY OF DISEASE, 2019, 122 : 23 - 34
  • [14] Autophagy is activated in systemic lupus erythematosus and required for plasmablast development
    Clarke, Alexander J.
    Ellinghaus, Ursula
    Cortini, Andrea
    Stranks, Amanda
    Simon, Anna Katharina
    Botto, Marina
    Vyse, Timothy J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (05) : 912 - 920
  • [15] Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
    Cohen, HY
    Miller, C
    Bitterman, KJ
    Wall, NR
    Hekking, B
    Kessler, B
    Howitz, KT
    Gorospe, M
    de Cabo, R
    Sinclair, DA
    [J]. SCIENCE, 2004, 305 (5682) : 390 - 392
  • [16] SLC39A8 missense variant is associated with Crohn's disease but does not have a major impact on gut microbiome composition in healthy subjects
    Collij, Valerie
    Imhann, Floris
    Vila, Arnau Vich
    Fu, Jingyuan
    Dijkstra, Gerard
    Festen, Eleonora A. M.
    Voskuil, Michiel D.
    Daly, Mark J.
    Xavier, Ramnik J.
    Wijmenga, Cisca
    Zhernakova, Alexandra
    Weersma, Rinse K.
    [J]. PLOS ONE, 2019, 14 (01):
  • [17] Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy
    Crews, Leslie
    Spencer, Brian
    Desplats, Paula
    Patrick, Christina
    Paulino, Amy
    Rockenstein, Edward
    Hansen, Lawrence
    Adame, Anthony
    Galasko, Douglas
    Masliah, Eliezer
    [J]. PLOS ONE, 2010, 5 (02):
  • [18] Parkinson's disease: Mechanisms and models
    Dauer, W
    Przedborski, S
    [J]. NEURON, 2003, 39 (06) : 889 - 909
  • [19] The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
    Davis, Beckley K.
    Wen, Haitao
    Ting, Jenny P. -Y.
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, VOL 29, 2011, 29 : 707 - 735
  • [20] KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
    De Roock, Wendy
    De Vriendt, Veerle
    Normanno, Nicola
    Ciardiello, Fortunato
    Tejpar, Sabine
    [J]. LANCET ONCOLOGY, 2011, 12 (06) : 594 - 603